New generation vaccines /

Saved in:

Bibliographic Details
Edition:	2nd ed., rev. and expanded.
Imprint:	New York : M. Dekker, 1997.
Description:	xvi, 1214 p. : ill. ; 29 cm.
Language:	English
Subject:	Vaccines. Vaccines. Vaccines.
Format:	E-Resource Print Book
URL for this record:	http://pi.lib.uchicago.edu/1001/cat/bib/2902982

Hidden Bibliographic Details
Other authors / contributors:	Levine, Myron M. (Myron Max), 1944-
ISBN:	0824700619 (hardcover : alk. paper)
Notes:	Includes bibliographical references and index.

Table of Contents:

1. Vaccines and Vaccination in Historical Perspective / Myron M. Levine and Rosanna Lagos
2. The Traditional Vaccines: An Overview / Gordon L. Ada
3. An Overview of Biotechnology as Applied to Vaccine Development / Graeme C. Woodrow
4. Initial Clinical Evaluation of New Vaccine Candidates: Phase 1 and 2 Clinical Trials of Safety, Immunogenicity, and Preliminary Efficacy / Carol O. Tacket, Tacket J. Mattheis and Margaret Baker Rennels
5. Long-Term Evaluation of Vaccine Protection: Methodological Issues for Phase 3 Trials and Phase 4 Studies / John D. Clemens, Abdollah Naficy and Malla R. Rao
6. Economic Analyses of Vaccines and Vaccination Programs: Evaluating the Economic Rationale for Immunization / Orin S. Levine and Benjamin Schwartz
7. Reaping the Benefits: Getting Vaccines to Those Who Need Them / J. W. Lee, Bruce Aylward and Harry F. Hull [et al.]
8. Progress and Challenges in Modern Vaccinology: An Immunologist's Perspective / Gustav J. V. Nossal
9. The Eradication of Vaccine-Preventable Diseases / William Foege
10. Recent Advances in Immunology: Impact on Vaccine Development / Marcelo B. Sztein and Graham F. Mitchell
11. Computer Prediction of T-Cell Epitopes / Anne S. De Groot, Gabriel E. Meister and James L. Cornette [et al.]
12. Identification of B- and T-Cell Epitopes Through Structural Characterization and Peptide Technology / Juan A. Cooper and Allan J. Saul
13. The Gastrointestinal Mucosal Immune System / Stephen P. James
14. Adjuvants for the Future / Robert Edelman
15. Proteosomes for Improved Nasal, Oral, or Injectable Vaccines / George H. Lowell
16. Liposomes as Adjuvants for Vaccines / Carl R. Alving
17. Prospects for the Development of New and Improved Vaccines Through the Use of Microencapsulation Technology / Derek T. O'Hagan
18. Antigen Cochleate Preparations for Oral and Systemic Vaccination / Raphael J. Mannino and Susan Gould-Fogerite
19. Ty Virus-like Particles as an Antigen Delivery System / Guy T. Layton
20. Immunopotentiating Reconstituted Influenza Virosomal Vaccine Delivery System / Reinhard Gluck and Stanley J. Cryz, Jr.
21. Mutant Pertussis and Escherichia coli Heat-Liable Toxins as Adjuvants for Enhancing Local and Systemic Immune Responses to Coadministered, Nonliving Antigens / Gillian Douce, Gordon Dougan and MariaGrazia Pizza [et al.]
22. Oral Vaccine Production in the Edible Tissues of Transgenic Plants / Charles J. Arntzen and Hugh S. Mason
23. DNA-Based Vaccines: Extending the Technology / Stephen Albert Johnston, Kathryn F. Sykes and Michael A. Barry
24. Vaccination Against Influenza with Plasmid DNA: Cross-Strain and Homologous Protection / John J. Donnelly, Jeffrey B. Ulmer and Margaret A. Liu
25. Vaccinia Virus as a Live Vector for Expression of Immunogens / Charles Flexner and Bernard Moss
26. Attenuated Poliovirus as Live Vector / Matthias Gromeier, Hui-Hua Lu and Steffen Mueller [et al.]
27. Attenuated Salmonella as a Live Vector for Expression of Foreign Antigens. i. Expressing Bacterial Antigens / S. N. Chatfield and Gordon Dougan. ii. Carrying Viral Antigens / Fiorian Schodel. iii. Salmonella Expressing Protozoal Antigens / Myron M. Levine, James E. Galen and Marcelo B. Sztein [et al.]
28. BCG as a Recombinant Vaccine Vector / Glenn J. Fennelly, William R. Jacobs, Jr. and Barry R. Bloom
29. Attenuated Vibrio cholerae as a Live Vector for Expression of Foreign Antigens / Joan R. Butterton and Stephen B. Calderwood
30. New and Improved Vaccines Against Pertussis / Erik L. Hewlett and James D. Cherry
31. New and Improved Vaccines Against Diphtheria and Tetanus / Rino Rappuoli
32. Progress in Development of New Attenuated Strains of Salmonella typhi as Live Oral Vaccines Against Typhoid Fever / Myron M. Levine, Carol O. Tacket and James E. Galen [et al.]
33. New and Improved Vaccines Against Cholera. i. Attenuated Vibrio cholerae O1 and O139 Strains as Live Oral Cholera Vaccines / James B. Kaper, Carol O. Tacket and Myron M. Levine. ii. Oral B Subunit Killed Whole-Cell Cholera Vaccine / Jan Holmgren, Marianne Jertborn and Ann-Mari L. Svennerholm
34. New and Improved Vaccines Against Meningococcal Disease / Wendell D. Zollinger
35. Epidemiological Impact of Conjugate Vaccines on Invasive Disease Caused by Haemophilus influenzae Type b / Jay D. Wenger, Robert Booy and Paul T. Heath [et al.]
36. Conjugate Vaccines Against Streptococcus pneumoniae / David L. Klein and Ronald W. Ellis
37. Vaccine Development for Rickettsial Infections: Rocky Mountain Spotted Fever, Epidemic Typhus, and Scrub Typhus / Kimberly W. Schuenke and David H. Walker
38. New and Improved Vaccines Against Influenza / Mary Lou Clements and Ina Stephens
39. New Vaccines Against Hepatitis A / Jack T. Stapleton and Stanley M. Lemon
40. New and Improved Vaccines for Dengue, Japanese Encephalitis, and Yellow Fever Viruses / Niranjan Kanesa-thasan, Robert Putnak and Charles H. Hoke, Jr.
41. Improved Vaccines Against Rabies / Zhen Fang Fu, Bernhard Dietzschold and Stanley A. Plotkin [et al.]
42. Combination Vaccines for Routine Infant Immunization: Prospects, Progress, and Dilemmas / Carole Heilman and N. Regina Rabinovich
43. New Vaccines Against Tuberculosis / Douglas Young and Uli Fruth
44. Live Attenuated Varicella Vaccines / Michiaki Takahashi and Anne A. Gershon
45. Vaccines Against Rotavirus / Paul A. Offit, H. Fred Clark and Albert Z. Kapikian
46. Experimental HIV-1 Vaccines / Mary Lou Clements
47. Vaccines Against Respiratory Syncytial Virus and Parainfluenza Virus Type 3 / James E. Crowe, Jr., Peter L. Collins and Robert M. Chanock [et al.]
48. Herpes Simplex Vaccines / Richard J. Whitley
49. Vaccines Against Arenaviruses and Filoviruses / J. Christopher S. Clegg and Anthony Sanchez
50. Vaccines Against Papillomavirus Infections / Robert W. Tindle and Ian H. Frazer
51. Vaccines Against Streptococcus pyogenes Infections / Debra E. Bessen and Vincent A. Fischetti
52. O-Specific Polysaccharide-Protein Conjugates for Prevention of Enteric Bacterial Diseases / John B. Robbins, Rachel Schneerson and Shousun C. Szu
53. Vaccines Against Gonococcal Infection / Timothy A. Mietzner and Myron S. Cohen
54. Vaccines Against Shigella Infections. i. Escherichia coli- or Salmonella typhi-Expressing Shigella Antigens / Thomas Larry Hale and Malabi M. Venkatesan. ii. Engineered Attenuated Mutants of Shigella as Live Oral Vaccines / Fernando Noriega, Samuel B. Formal and Karen L. Kotloff [et al.]
55. Vaccines Against Enterotoxigenic Escherichia coli Infections. i. Oral Inactivated Vaccines Against Enterotoxigenic Escherichia coli / Ann-Mari L. Svennerholm, Christina Ahren and Marianne Jertborn. ii. Live Oral Vaccines and Subunit (Purified Fimbriae and Toxin Subunit) Vaccines / Carol O. Tacket and Myron M. Levine
56. Vaccines Against Campylobacter jejuni / Daniel A. Scott, Shahida Baqar and Donald H. Burr [et al.]
57. Vaccines Against Lyme Disease / Robert Edelman
58. Vaccines Against Dental Caries Infection / Daniel J. Smith and Martin A. Taubman
59. Vaccines Against Klebsiella, Pseudomonas, and Septicemic E. coli Infections / Alan S. Cross and Stanley J. Cryz, Jr.
60. Vaccines Against Escherichia coli and Proteus Urinary Tract Infections / Harry L. T. Mobley
61. Vaccines Against Helicobacter pylori / Adrian Lee and Christopher Doidge
62. Vaccines for Staphylococcus aureus Infections / Ali I. Fattom and Robert B. Naso
63. Vaccines Against Malaria. i. Synthetic Peptide Vaccines Against the Sporozoite Stage of Plasmodium / Elizabeth H. Nardin and Ruth S. Nussenzweig. ii. Vaccines Designed to Induced Protective T-Cell Reponses Against Plasmodium-Infected Hepatocytes / John B. Sacci, Jr., Eileen D. Franke and Stephen L. Hoffman. iii. Spf66 Vaccine Against Asexual Erythrocytic Stages of P. falciparum / Roberto Amador and Manuel E. Patarroyo.
iv. Vaccines Against Asexual Blood Stages of Plasmodium falciparum / Robin F. Anders. v. Vaccines Against Sexual-Stage Parasites of P. falciparum: Transmission-Blocking Vaccines / David C. Kaslow
64. Vaccines Against Leishmaniasis / Carol L. Eisenberger and Charles L. Jaffe
65. Vaccines Against Schistosomiasis / Gilles J. Riveau and Andre Capron
66. Antitumor Vaccines / Karl Erik Hellstrom, Ingegerd Hellstrom and Lieping Chen
67. Vaccine Therapy / Donald S. Burke
68. Vaccines to Prevent Pregnancy / Vernon C. Stevens and Warren R. Jones
69. An Anti-arthropod Vaccine: TickGARD - A Vaccine to Prevent Cattle Tick Infestations / Gary S. Cobon
70. Large-Scale Production of Live Attenuated Bacterial and Viral Vaccines / Stanley J. Cryz, Jr. and Reinhard Gluck
71. Vaccine Development: The Long Road from Initial Idea to Product Licensure / Jens-Peter Gregersen
72. Inadvertant Nontarget Effects of Live Vaccines / Myron M. Levine and Eileen M. Barry
73. The Role of the Food and Drug Administration in Vaccine Testing and Licensure / Bascomb F. Anthony and Ann Sutton.

New generation vaccines /

Similar Items